Genetics/Genomics

Top Story

Cardiology Today's top articles from the NLA Scientific Sessions

June 24, 2017

The National Lipid Association Annual Scientific Session s featur ed intensive sessions on major topics in lipid research and the future of health care . Cardiology Today has compiled a list of the top studies, presentations and abstracts presented at the meeting this year.

Gene of the Month

Discovery of six new genetic risk variants predisposing to CAD

Cardiology Today, June 2017
Arlene Campillo, BS; Robert Roberts, MD, MACC, FRSC, FRCPC, LLD (Hon.)
Much work has been put in to discovering genetic variants predisposing to CAD since the first, 9p21, was discovered in 2007. The CAD phenotype in the original study and…
In the JournalsPerspective

ANGPTL3 antagonism may further decrease lipid levels, risk for CVD

June 2, 2017
Therapeutic and genetic antagonism of angiopoietin-like 3 decreased lipid levels and the risk for atherosclerotic CVD, according to a study in The New England Journal of
Meeting News

Personalized medicine may help patients with familial hypercholesterolemia

May 25, 2017
PHILADELPHIA — Genomics, proteomics and imaging may enable a personalized medicine strategy for patients with familial hypercholesterolemia, an expert said at the…

Cardiology Today's top articles from the NLA Scientific Sessions

June 24, 2017
The National Lipid Association Annual Scientific Session s featur ed intensive sessions on major topics in lipid research and the future of health…

Gene of the Month

Discovery of six new genetic risk variants predisposing to CAD

Cardiology Today, June 2017
Arlene Campillo, BS; Robert Roberts, MD, MACC, FRSC, FRCPC, LLD (Hon.)
Much work has been put in to discovering genetic variants predisposing to CAD since the first, 9p21, was discovered in 2007. The CAD phenotype in the…

In the JournalsPerspective

ANGPTL3 antagonism may further decrease lipid levels, risk for CVD

June 2, 2017
Therapeutic and genetic antagonism of angiopoietin-like 3 decreased lipid levels and the risk for atherosclerotic CVD, according to a study in The

Meeting News

Personalized medicine may help patients with familial hypercholesterolemia

May 25, 2017
PHILADELPHIA — Genomics, proteomics and imaging may enable a personalized medicine strategy for patients with familial hypercholesterolemia, an…

Meeting News

Damaging mutations in ABCA1, APOA1 linked to atherosclerosis

May 19, 2017
PHILADELPHIA — In patients with low HDL, a damaging mutation in ABCA1 or APOA1 is associated with an increased risk for subclinical…

In the Journals

Blood test for patients with CAD symptoms may reduce unnecessary cardiac referrals

April 28, 2017
Patients with symptoms of obstructive CAD with a low score using a blood-based age/sex/gene expression test were less likely to be referred to a…

In the JournalsPerspective

ANGPTL3 loss-of-function mutation may confer lower risk for CAD

April 17, 2017
Individuals with a deficiency of angiopoietin-like 3 had a decreased risk for CAD, even in the presence of risk factors, according to findings in the…

Cardiology Today's top stories covered at the ACC Scientific Session

April 13, 2017
The American College of Cardiology Scientific Session featured important late- break ing clinical trials and other material presented by some of the…

In the Journals

Autoantibodies against GPIHBP1 protein found to cause hypertriglyceridemia

April 10, 2017
Researchers have determined a cause for severe hypertriglyceridemia and chylomicronemia. Stephen G. Young, MD, distinguished professor of…

Meeting NewsPerspective

GIFT: Genetics-based dosing improves warfarin safety

March 19, 2017
WASHINGTON — Pharmacogenetics-based warfarin dosing decreased adverse events compared with clinical-based dosing, investigators from the GIFT…

More Headlines »
Advertisement
Advertisement